Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance

Abstract

Cancer is one of the most harmful diseases in the world, which causes huge numbers of deaths every year. Many drugs have been developed to treat tumors. However, drug resistance usually develops after a period of time, which greatly weakens the therapeutic effect. Tumor drug resistance is characterized by blocking the action of anticancer drugs, resisting apoptosis and DNA repair, and evading immune recognition. To tackle tumor drug resistance, many engineered drug delivery systems (DDS) have been developed. Metal-organic frameworks (MOFs) are one kind of emerging and promising nanocarriers for DDS with high surface area and abundant active sites that make the functionalization simpler and more efficient. These features enable MOFs to achieve advantages easily towards other materials. In this review, we highlight the main mechanisms of tumor drug resistance and the characteristics of MOFs. The applications and opportunities of MOF-based DDS to overcome tumor drug resistance are also discussed, shedding light on the future development of MOFs to address tumor drug resistance.

Keywords

Metal-organic framework / drug resistance / drug delivery / cancer therapy / nanosystem

References

[1] Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Nie Y,Peng Y.Metal organic framework coated MnO₂ nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer.Int J Pharm2020;585:119513

[3] Chen J,Yuan Y.Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair-inhibiting (HYDRI) nanomedicine.Sci Adv2021;7:eabc5267 PMCID:PMC7997498

[4] Jiang Q,Sun Q,Xuan Z.Enhancing the antitumor effect of doxorubicin with photosensitive metal-organic framework nanoparticles against breast cancer.Mol Pharm2021;18:3026-36

[5] Li H,Liang L.Doxorubicin-loaded metal-organic framework nanoparticles as acid-activatable hydroxyl radical nanogenerators for enhanced chemo/chemodynamic synergistic therapy.Materials2022;15:1096 PMCID:PMC8838206

[6] Koppula P,Zhang Y.A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.Nat Commun2022;13:2206 PMCID:PMC9033817

[7] Pan Q,Liu R.Two birds with one stone: copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.Int J Pharm2022;612:121351

[8] Wang F,Xin H.Triple-layered metal-organic framework hybrid for tandem response-driven enhanced chemotherapy.Chem Asian J2021;16:2068-74

[9] Li J,Zheng X,Li X.A triple-combination nanotechnology platform based on multifunctional RNA hydrogel for lung cancer therapy.Sci China Chem2020;63:546-53

[10] Hao K,Sun P.Cationic flexible organic framework for combination of photodynamic therapy and genetic immunotherapy against tumors.Small2021;17:e2008125

[11] Zhang L,Hu C.CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.Mol Cancer2022;21:103 PMCID:PMC9027122

[12] Liu Y,Shi Y.Two-dimensional intermetallic PtBi/Pt core/shell nanoplates overcome tumor hypoxia for enhanced cancer therapy.Nanoscale2021;13:14245-53

[13] Geng Z,Liu K,Tan W.Enhancing anti-PD-1 immunotherapy by nanomicelles self-assembled from multivalent aptamer drug conjugates.Angew Chem Int Ed2021;60:15459-65

[14] Yi X,Chao Y.Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer.Sci Adv2020;6:eaba3546 PMCID:PMC7428325

[15] Wu J,Li KS,Zhang PF.Circular RNA drives resistance to anti-PD-1 immunotherapy by regulating the miR-30a-5p/SOX4 axis in non-small cell lung cancer.Cancer Drug Resist2022;5:261-70 PMCID:PMC9255236

[16] Nia HT,Jain RK.Physical traits of cancer.Science2020;370:eaaz0868 PMCID:PMC8274378

[17] Holohan C,Longley DB.Cancer drug resistance: an evolving paradigm.Nat Rev Cancer2013;13:714-26

[18] Wang H,Zhao G.Overcoming ovarian cancer drug resistance with a cold responsive nanomaterial.ACS Cent Sci2018;4:567-81 PMCID:PMC5968444

[19] Cheng Z,Dey R.Nanomaterials for cancer therapy: current progress and perspectives.J Hematol Oncol2021;14:85 PMCID:PMC8165984

[20] Luo X,Chen H,Zeng N.Smart nanoparticles for breast cancer treatment based on the tumor microenvironment.Front Oncol2022;12:907684 PMCID:PMC9204624

[21] Hou DY,Wang JQ.OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance.Biomaterials2022;284:121523

[22] Qin L,Shao K.A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis.Sci Adv2020;6:eabb3116 PMCID:PMC7473750

[23] Liang M,Zhou M.H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.Proc Natl Acad Sci U S A2014;111:14900-5 PMCID:PMC4205604

[24] Zhu L,Xiong Y.Emerging self-assembling peptide nanomaterial for anti-cancer therapy.J Biomater Appl2021;36:882-901

[25] Li D,Fan Y.Ultrasound-enhanced fluorescence imaging and chemotherapy of multidrug-resistant tumors using multifunctional dendrimer/carbon dot nanohybrids.Bioact Mater2021;6:729-39 PMCID:PMC7519212

[26] Hu Y,Majoral JP,Shi X.Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.Chem Soc Rev2018;47:1874-900

[27] Chenyang Y,Li S.Magnetically switchable mechano-chemotherapy for enhancing the death of tumour cells by overcoming drug-resistance.Nano Today2020;35:100967

[28] Yang B,Zeng J.Super-assembled core-shell mesoporous silica-metal-phenolic network nanoparticles for combinatorial photothermal therapy and chemotherapy.Nano Res2020;13:1013-9

[29] Xia Y,Yao H,Ning P.Engineering macrophages for cancer immunotherapy and drug delivery.Adv Mater2020;32:e2002054

[30] Liu B,Zhao J,Li L.A smart DNA nanodevice for ATP-activatable bioimaging and photodynamic therapy.Sci China Chem2020;63:1490-7

[31] Hu XY,Yang ZW,Liu J.Cancer drug resistance related microRNAs: recent advances in detection methods.Analyst2022;147:2615-32

[32] Gautam M,Yong CS.Prussian blue nanoparticles: synthesis, surface modification, and application in cancer treatment.Int J Pharm2018;549:31-49

[33] Lian X,Zhu Y.Enzyme-MOF nanoreactor activates nontoxic paracetamol for cancer therapy.Angew Chem Int Ed2018;57:5725-30 PMCID:PMC6621563

[34] Ni D,Zhang N.Combinational application of metal-organic frameworks-based nanozyme and nucleic acid delivery in cancer therapy.WIREs Nanomed Nanobi2022;14:e1773

[35] Chen Z,Zhang M.Interfering with lactate-fueled respiration for enhanced photodynamic tumor therapy by a porphyrinic MOF nanoplatform.Adv Funct Mater2018;28:1803498

[36] Hu L,Wei G.Stimuli-responsive charge-reversal MOF@polymer hybrid nanocomposites for enhanced co-delivery of chemotherapeutics towards combination therapy of multidrug-resistant cancer.J Colloid Interface Sci2022;608:1882-93

[37] Wu Q,Sun X.MnMOF-based microwave-glutathione dual-responsive nano-missile for enhanced microwave Thermo-dynamic chemotherapy of drug-resistant tumors.Chem Eng J2022;439:135582

[38] Sun X,Xu L.Heparin coated meta-organic framework co-delivering doxorubicin and quercetin for effective chemotherapy of lung carcinoma.J Int Med Res2020;48:300060519897185 PMCID:PMC7111025

[39] Du B,Ma H.Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance.J Nanobiotechnology2022;20:209 PMCID:PMC9063293

[40] Wang JW,Luo GF.A self-driven bioreactor based on bacterium-metal-organic framework biohybrids for boosting chemotherapy via cyclic lactate catabolism.ACS Nano2021;15:17870-84

[41] Tong PH,Zang Y,He XP.Metal-organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics.Chem Commun2021;57:12098-110

[42] Wang Z,Zhao C,Ren J.A bimetallic metal-organic framework encapsulated with DNAzyme for intracellular drug synthesis and self-sufficient gene therapy.Angew Chem Int Ed2021;60:12431-7

[43] Li L,Carmona U.Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells.Biomaterials2016;98:143-51

[44] Du L,Xiao Z.GSH-responsive metal-organic framework for intratumoral release of NO and IDO inhibitor to enhance antitumor immunotherapy.Small2022;18:e2107732

[45] Yang H,Zeng L.Cell-selective encapsulation within metal-organic framework shells via precursor-functionalized aptamer identification for whole-cell cancer vaccine.Small Methods2022;6:e2101391

[46] Xu M,Ding W.Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance.Biomaterials2020;258:120308

[47] Li F,Wang F.Enhanced cancer starvation therapy enabled by an autophagy inhibitors-encapsulated biomimetic ZIF-8 nanodrug: disrupting and harnessing dual pro-survival autophagic responses.ACS Appl Mater Interfaces2022;14:21860-71

[48] Han H,Chen X.Metformin-induced stromal depletion to enhance the penetration of gemcitabine-loaded magnetic nanoparticles for pancreatic cancer targeted therapy.J Am Chem Soc2020;142:4944-54

[49] Xin X,Lin F.Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy.Sci Adv2020;6:eabd6764 PMCID:PMC7673723

[50] Chen J,Hu Y.A folic acid-modified non-viral vector combines gene therapy with chemotherapy to reverse cancer chemotherapy resistance.Appl Mater Today2022;26:101277

[51] Chen K,Jiang Z.Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.Mol Cancer2017;16:131 PMCID:PMC5525317

[52] Ruan L,Du C.Mitochondrial temperature-responsive drug delivery reverses drug resistance in lung cancer.Bioact Mater2022;13:191-9 PMCID:PMC8844157

[53] Ortiz M,Mitchell K.Mechanisms of chemotherapy resistance in ovarian cancer.Cancer Drug Resist2022;5:304-16 PMCID:PMC9255249

[54] Wang MM,Su Y.A new strategy to fight metallodrug resistance: mitochondria-relevant treatment through mitophagy to inhibit metabolic adaptations of cancer cells.Angew Chem Int Ed2022;61:e202203843

[55] Peng H,Yang P.Defect self-assembly of metal-organic framework triggers ferroptosis to overcome resistance.Bioact Mater2023;19:1-11 PMCID:PMC8980498

[56] Wang K,Zhou J,Zong Q.Tumor-acidity and bioorthogonal chemistry-mediated on-site size transformation clustered nanosystem to overcome hypoxic resistance and enhance chemoimmunotherapy.ACS Nano2022:721-35

[57] Baek S,Deng Y.Quenching epigenetic drug resistance using antihypoxic microparticles in glioblastoma patient-derived chips.Adv Healthcare Materials2022;11:2102226

[58] Yamamoto K,Yano J.Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.Nature2020;581:100-5 PMCID:PMC7296553

[59] Lopez A,Gitego N.Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer.Nat Commun2022;13:1199 PMCID:PMC8901805

[60] Qi Z,Zhang L.Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment.Nat Commun2022;13:182 PMCID:PMC8748754

[61] Wu S,Tao B.Pyruvate facilitates FACT-mediated γH2AX loading to chromatin and promotes the radiation resistance of glioblastoma.Adv Sci2022;9:e2104055 PMCID:PMC8922107

[62] Chen Q,Zheng W,Deng H.Se/Ru-decorated porous metal-organic framework nanoparticles for the delivery of pooled siRNAs to reversing multidrug resistance in taxol-resistant breast cancer cells.ACS Appl Mater Interfaces2017;9:6712-24

[63] Caushi JX,Ji Z.Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.Nature2021;596:126-32 PMCID:PMC8338555

[64] Joung J,Singh A.CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.Nat Commun2022;13:1606 PMCID:PMC8956604

[65] Huang AC.A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance.Nat Immunol2022;23:660-70 PMCID:PMC9106900

[66] Mair F,Frutoso M.Extricating human tumour immune alterations from tissue inflammation.Nature2022;605:728-35 PMCID:PMC9132772

[67] Guo Y,Chen Y.Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.Sci Adv2021;7:eabd7455 PMCID:PMC8139582

[68] Mirzaei R,Zemp FJ.PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway.Sci Adv2021;7:eabh2148 PMCID:PMC8570610

[69] Topalian SL,Pardoll DM.Neoadjuvant checkpoint blockade for cancer immunotherapy.Science2020;367:eaax0182 PMCID:PMC7789854

[70] Xie X,Zhang H.Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy.Bioact Mater2022;16:107-19 PMCID:PMC8958467

[71] Liu M,Capistrano KJ.TGF-β suppresses type 2 immunity to cancer.Nature2020;587:115-20 PMCID:PMC8347705

[72] Lv J,Mo S.Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway.Nat Cell Biol2022;24:364-72 PMCID:PMC8924000

[73] Ulldemolins A,Andrade F.Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics.Cancer Drug Resist2021;4:44-68 PMCID:PMC9019183

[74] Wang W,Liu S.An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer.Mol Cancer2022;21 PMCID:PMC9044593

[75] Zhang LX,Long X.The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.Mol Cancer2022;21:110 PMCID:PMC9077876

[76] Jiang J,Zheng H.Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances.Biomaterials2022;285:121561

[77] Aldonza MBD,Hong JY.Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms.Sci Adv2020;6:eaav7416 PMCID:PMC7007258

[78] Tiek D.DNA damage and metabolic mechanisms of cancer drug resistance.Cancer Drug Resist2022;5:368-79 PMCID:PMC9255237

[79] Serratì S,Di Fonte R.Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.Mol Cancer2022;21:20 PMCID:PMC8764806

[80] Saha B,Tronolone JJ.Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer.Sci Adv2021;7:eabg5283 PMCID:PMC8294767

[81] Wang X,Wang Z.Platelets involved tumor cell EMT during circulation: communications and interventions.Cell Commun Signal2022;20:82 PMCID:PMC9166407

[82] Cai G,Zhang L,Jiang HL.Metal-organic framework-based hierarchically porous materials: synthesis and applications.Chem Rev2021;121:12278-326

[83] Ren H.Electrochemical synthesis methods of metal-organic frameworks and their environmental analysis applications: a review.ChemElectroChem2022;9

[84] Zhuang J,Chou LY,Weerapana E.Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation.ACS Nano2014;8:2812-9

[85] Liang K,Doherty CM.Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules.Nat Commun2015;6:7240 PMCID:PMC4468859

[86] Peng S,Sun Y.Metal-organic frameworks for precise inclusion of single-stranded DNA and transfection in immune cells.Nat Commun2018;9:1293 PMCID:PMC5882967

[87] Haydar M, Abid HR, Sunderland B, Wang S. Metal organic frameworks as a drug delivery system for flurbiprofen.Drug Des Devel Ther2017;11:2685-95 PMCID:PMC5602417

[88] Yang Y,Wu JP.Reduction-responsive codelivery system based on a metal-organic framework for eliciting potent cellular immune response.ACS Appl Mater Interfaces2018;10:12463-73

[89] Zhao M,Yang W.Assembly of ionic liquid molecule layers on metal-organic framework-808 for CO2 capture.Chem Eng J2022;439:135650

[90] Jiang S,Chen L.A strongly hydrophobic ethane-selective metal-organic framework for efficient ethane/ethylene separation.Chem Eng J2022;442:136152

[91] Yu K,Li Z,Wang Z.Construction of molecular sensing and logic systems based on site-occupying effect-modulated MOF-DNA interaction.J Am Chem Soc2020;142:21267-71

[92] Gao H,Li M,Wei T.Co-quenching effect between lanthanum metal-organic frameworks luminophore and crystal violet for enhanced electrochemiluminescence gene detection.Small2021;17:e2103424

[93] Jiang ZW,Li CM,Huang CZ.2D MOF-based photoelectrochemical aptasensor for SARS-CoV-2 spike glycoprotein detection.ACS Appl Mater Interfaces2021;13:49754-61 PMCID:PMC8547163

[94] Li Y,He Y.A generic and non-enzymatic electrochemical biosensor integrated molecular beacon-like catalyzed hairpin assembly circuit with MOF@Au@G-triplex/hemin nanozyme for ultrasensitive detection of miR-721.Biosens Bioelectron2022;203:114051

[95] Sharabati M, Sabouni R, Husseini GA. Biomedical applications of metal-organic frameworks for disease diagnosis and drug delivery: a review.Nanomaterials2022;12:277 PMCID:PMC8780624

[96] Ni W,Fang H.Photothermal-chemotherapy enhancing tumor immunotherapy by multifunctional metal-organic framework based drug delivery system.Nano Lett2021;21:7796-805

[97] Liu J,Cheng Y.Copper-based metal-organic framework overcomes cancer chemoresistance through systemically disrupting dynamically balanced cellular redox homeostasis.J Am Chem Soc2022;144:4799-809

[98] Hidalgo T,Bouzo BL.Biocompatible iron(III) carboxylate metal-organic frameworks as promising RNA nanocarriers.Nanoscale2020;12:4839-45

[99] Lei Z,Lin Y.Reactive oxygen species synergistic pH/H₂O₂-responsive poly(l-lactic acid)-block-poly(sodium 4-styrenesulfonate)/citrate-Fe(III)@ZIF-8 hybrid nanocomposites for controlled drug release.ACS Appl Bio Mater2019;2:3648-58

[100] Zhu Y,Qiao Z.Bioactive MOFs based theranostic agent for highly effective combination of multimodal imaging and chemo-phototherapy.Adv Healthc Mater2020;9:e2000205

[101] Cheng Y,Sun Y,Yin X.Mixed-metal MOF-derived hollow porous nanocomposite for trimodality imaging guided reactive oxygen species-augmented synergistic therapy.Adv Funct Mater2021;31:2104378

[102] Li S,Tan L.MOF@COF nanocapsule for the enhanced microwave thermal-dynamic therapy and anti-angiogenesis of colorectal cancer.Biomaterials2022;283:121472

[103] Wang D,Zhao Y.Metal-organic framework derived nanozymes in biomedicine.Acc Chem Res2020;53:1389-400

[104] Feng L,Joseph E.Catalytic porphyrin framework compounds.Trends in Chemistry2020;2:555-68

[105] Huang N,Drake H.Systematic engineering of single substitution in zirconium metal-organic frameworks toward high-performance catalysis.J Am Chem Soc2017;139:18590-7

[106] Zhao Y,Niu Z.Robust corrole-based metal-organic frameworks with rare 9-connected Zr/Hf-Oxo clusters.J Am Chem Soc2019;141:14443-50

[107] Zhang H,Liu R.Rational design of metal organic framework nanocarrier-based codelivery system of doxorubicin hydrochloride/verapamil hydrochloride for overcoming multidrug resistance with efficient targeted cancer therapy.ACS Appl Mater Interfaces2017;9:19687-97

[108] Cheng G,Ha L.Self-assembly of extracellular vesicle-like metal-organic framework nanoparticles for protection and intracellular delivery of biofunctional proteins.J Am Chem Soc2018;140:7282-91

[109] Cheng H,Zheng RR.A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy.Biomaterials2019;195:75-85

[110] Liu P,Shi X.A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances.J Nanobiotechnology2021;19:149 PMCID:PMC8139056

[111] Li J,Xu J.S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.Nat Commun2022;13:1481 PMCID:PMC8933470

[112] Yu Z,Pan W,Tang B.A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis.Nat Commun2018;9:5044 PMCID:PMC6262009

[113] Jaaks P,Vis DJ.Effective drug combinations in breast, colon and pancreatic cancer cells.Nature2022;603:166-73 PMCID:PMC8891012

[114] Ling D,Xi W.Heterodimers made of metal-organic frameworks and upconversion nanoparticles for bioimaging and pH-responsive dual-drug delivery.J Mater Chem B2020;8:1316-25

[115] Zhang SM,Liu X.KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.Nature2021;598:682-7 PMCID:PMC8555464

[116] Larsen BD,Yung PYK.Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress.Science2022;376:476-83

[117] Cao X,Li B.Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy.Sci Adv2022;8:eabl9171 PMCID:PMC8932662

[118] Li Y,Gao H.ZIF-based nanoparticles combine X-ray-induced nitrosative stress with autophagy management for hypoxic prostate cancer therapy.Angew Chem Int Ed2021;60:15472-81